Please assess the completion status of the following clinical trial:

Trial Title: Esophageal Temperature Management During Cryo AF Ablation (EnsoETM)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients above the age of 18 years old.~2. Patients with the diagnosis of atrial fibrillation undergoing clinically indicated de-novo AF ablation procedure.~3. Patients must be willing to provide informed consent.~Exclusion Criteria:~1. Patients with contraindication to EGD.~2. History of prior AF ablation procedures.~3. Significant co-morbidities that preclude standard ablation procedure.~4. Patient is ineligible for EnsoETM placement due to:~   * Known esophageal deformity or evidence of esophageal trauma (for example history of esophagectomy, previous swallowing disorders, achalasia).~  * Known ingestion of acidic or caustic poisons within the prior 24 hours.~  * Patients with \<40 kg of body mass.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): Placement of study device (EnsoETM) for temperature management
- Control (Type: ACTIVE_COMPARATOR): Placement of standard temperature probe

Based on this trial design, predict the completion outcome and termination type (if applicable).